Anti-N-methyl-D-aspartic acid receptor encephalitis after recurrent herpes simplex infection: A case report and literature review
Authors:
- Alexandra B. KornbluhAKAlexandra B. Kornbluh
- Loren McLendonLMLoren McLendon
- Brenda BanwellBBBrenda Banwell
Open Access
- 8 October 2022
- journal article
- review article
- Published by Elsevier in Neuroimmunology Reports
- Vol. 2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Clinical outcomes in children with herpes simplex encephalitis receiving steroid therapyJournal of Clinical Virology, 2016
- Immune therapy in autoimmune encephalitis: a systematic reviewExpert Review of Neurotherapeutics, 2015
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Pediatric Herpes Simplex Virus EncephalitisJournal of Child Neurology, 2013
- The Rehabilitation of Children with Anti–N-methyl-D-aspartate–Receptor EncephalitisAmerican Journal of Physical Medicine & Rehabilitation, 2012
- Oral Acyclovir Suppression and Neurodevelopment after Neonatal HerpesNew England Journal of Medicine, 2011
- Neuropsychologic Outcomes in Children With Neonatal Herpes EncephalitisPediatric Neurology, 2008
- Improved Neurodevelopmental Outcomes following Long-Term High-Dose Oral Acyclovir Therapy in Infants with Central Nervous System and Disseminated Herpes Simplex DiseaseJournal of Perinatology, 2004
- Neonatal Herpes Simplex InfectionClinical Microbiology Reviews, 2004
- Experimental Herpes Simplex Virus Encephalitis: A Combination Therapy of Acyclovir and Glucocorticoids Reduces Long-Term Magnetic Resonance Imaging AbnormalitiesJournal of NeuroVirology, 2003